| Literature DB >> 28559880 |
Jie Yang1, Wenjuan Li1, Tzi Bun Ng2, Xiangzhen Deng1, Juan Lin1, Xiuyun Ye1.
Abstract
Laccases are a family of copper-containing oxidases with important applications in bioremediation and other various industrial and biotechnological areas. There have been over two dozen reviews on laccases since 2010 covering various aspects of this group of versatile enzymes, from their occurrence, biochemical properties, and expression to immobilization and applications. This review is not intended to be all-encompassing; instead, we highlighted some of the latest developments in basic and applied laccase research with an emphasis on laccase-mediated bioremediation of pharmaceuticals, especially antibiotics. Pharmaceuticals are a broad class of emerging organic contaminants that are recalcitrant and prevalent. The recent surge in the relevant literature justifies a short review on the topic. Since low laccase yields in natural and genetically modified hosts constitute a bottleneck to industrial-scale applications, we also accentuated a genus of laccase-producing white-rot fungi, Cerrena, and included a discussion with regards to regulation of laccase expression.Entities:
Keywords: PPCPs; antibiotics; bioremediation; expression regulation; laccase; production
Year: 2017 PMID: 28559880 PMCID: PMC5432550 DOI: 10.3389/fmicb.2017.00832
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Summary of laccase production by the genus .
| 0.5 | 7 | Glucose 20 g/L, | Cu2+ (8 μM) | Al-Adhami et al., | |
| 3.9 | 8 | Lindeberg-Holm medium (glucose 10 g/L, | Cu2+ (10 μM) added at 3 and 6 d | Janusz et al., | |
| 250 | 7/14 | Glucose 10 g/L, wheat bran (40 g/L), bacto peptone 2 g/L, yeast extract 2 g/L | Cu2+ (1 mM), wheat bran | Songulashvili et al., | |
| 416.4 | 12 | Glucose 5.5 g/L, wheat bran 40 g/L, peptone 2g/L, yeast extract 2g/L | Cu2+ (1 mM), wheat bran | Songulashvili et al., | |
| 18.7 | 12 | 50% eco-tomato juice | – | Michniewicz et al., | |
| 4 | 12 | Modified Kirk medium (glucose 13 g/L, di-ammonium tartrate 0.5 g/L, yeast extract 0.25 g/L) | Cu2+ (50 μM) | Michniewicz et al., | |
| 85.8 | 12 | B&K medium (glucose 10 g/L, peptone 2 g/L, yeast extract 1 g/L) | Textile effluent (1%) | D'Souza et al., | |
| 15 | 8 | Kirk medium with high nitrogen (0.9 g/L α-asparagine and NH4NO3) | Cu2+ (0.1 mM) | Lisova et al., | |
| 151.6 | 14 | Wheat bran 40 g/L | Wheat bran | Elisashvili and Kachlishvili, | |
| 165 | NA | Ethanol production residue 40 g/L, ammonium tartrate 2 g/L, yeast extract 3 g/L | 2,4,6-trinitrotoluene (0.5 mM) | Elisashvili and Kachlishvili, | |
| 20 | 4 | Ammonium tartrate 2 g/L, yeast extract 3 g/L, mannitol 10 | Cu2+ (0.1 mM), 2,4,6-trinitrotoluene (0.3 mM) | Elisashvili and Kachlishvili, | |
| 202 | 13 | 2.4% potato dextrose broth (Difco, BD), 5% soytone | Cu2+ (0.4 mM), 2,5-xylidine (2 mM) | Chen et al., | |
| 5 | 6 | Glucose 10 g/L, polypeptone 5 g/L, yeast extract 1 g/L | – | Hibi et al., | |
| 280 | 5 | Maltodextrin 60 g/L, peptone 10 g/L | Cu2+ (0.25 mM) | Yang et al., | |
| 2,800 | 8 | Potato dextrose medium | Cu2+ (1 mM) | Wang et al., |
Fermentation was carried out in a shake flask.
Enzyme activity was assayed with syringaldazine as the substrate.
Fermentation was carried out in a 2.5-L fermenter.
Enzyme activity was converted from nkat to U by dividing by 16.67.
Fermentation was carried out in a 120-L fermenter.
Fermentation was carried out in a 5-L fermenter.
Enzyme activity was assayed with Remazol Brilliant Blue R as the substrate.
Enzyme activity was assayed with ABTS as the substrate at 405 nm. Unless otherwise mentioned, enzyme activity was assayed with ABTS as the substrate at 420 nm. NA, not available.
Basidiomycete laccase gene families.
| 7 | 575–620 | Transcriptome | Lcc3/5 | Free-living and substrate mycelia and fruiting bodies | qRT-PCR | Fan et al., | |
| 8 | 516–542 | Cloning | Lac2/7 | Submerged fermentation | RT-PCR and LC-MS/MS | Yang et al., | |
| 17 | 516–567 | Genome | Lcc1/5 | Submerged fermentation | Zymograms and LC-MS/MS | Hoegger et al., | |
| 11 | 502–607 | Genome | Lac4 | Mycelia and fruiting bodies | Transcriptome | Wang W. et al., | |
| 9 | 504–540 | Genome | LCC3/7 | Mycelia, ectomycorrhizas and fruiting bodies | Custom whole-genome expression oligoarrays and qRT-PCR | Courty et al., | |
| 11 | 515–563 | Genome | – | Mycelia, fruiting bodies | qRT-PCR | Sakamoto et al., | |
| 11 | 516–541 | Genome | Lacc2/10 | Submerged fermentation, solid state fermentation, fruiting bodies | qRT-PCR | Castanera et al., | |
| 5 | 519–523 | cDNA library | LacA | Submerged fermentation | qRT-PCR | Vasina et al., | |
| 7 | 501–525 | Genome | LccA | Submerged fermentation | Native PAGE | Xiao et al., | |
| 11 | 508–562 | Genome | Lcc3 | Stipes | Digital gene expression (DGE) and qRT-PCR | Bao et al., |
The length of LacA-C.
Laccase applications in biodegradation and bioremediation in 2016.
| Chlorophenols, cresols, nitrophenols | In culture | – | Balcazar-Lopez et al., | |
| Technical nonylphenol | Free | SA | Hofmann and Schlosser, | |
| Oxybenzone, pentachlorophenol | Free | ABTS, HBT, HPI, TEMPO, SA, VA, VAN | Ashe et al., | |
| 4-tert-butylphenol, 4-tert-octylphenol | Enzymatic membrane reactor | SA | Nguyen et al., | |
| 2,4-dichlorophenol | Free | – | Rodríguez-Delgado et al., | |
| Bromophenol Blue, Congo Red, Coomassie Blue, Tripan Blue | Free | – | Balcazar-Lopez et al., | |
| Acid Black 172, Congo Red, Crystal Violet, Direct Fast Blue FBL, Indigo Blue, Naphthol Green B, Methylene Blue, Neutral Red, Reactive Brilliant Blue X-BR, Remazol Brilliant Blue Reactive (RBBR) | Chitosan beads | – | Zheng et al., | |
| Acid Orange 67, Basic Red 18, Basic Yellow 28, Direct Black 166, Direct Yellow 107, Disperse Yellow 79 | Free | HBT | Forootanfar et al., | |
| Brilliant Blue G, Brilliant Blue R, Bromophenol Blue, Coomassie Blue R250, Crystal Violet, Malachite Green, Methylene Blue, Xylene Cyanol, RBBR | Free | VA | Iracheta-Cárdenas et al., | |
| RBBR | Core-shell magnetic copper alginate beads | HBT | Le et al., | |
| RBBR | Cross-linked enzyme aggregates | – | Yang et al., | |
| Coomassie Blue R250 | Free | ABTS, AS, HBT, SA, SYA | Yang et al., | |
| Bisphenol A (BPA) | Free | HBT | Daâssi et al., | |
| BPA | In culture | – | Balcazar-Lopez et al., | |
| BPA | Surface display | ABTS | Chen et al., | |
| BPA | Cross-linked carbon nanotubes-based biocatalytic membranes | – | Ji et al., | |
| BPA | On granular activated carbon, continuous flow packed-bed reactor | – | Nguyen et al., | |
| BPA, 17α-ethinylestradiol | Polyamide 6/chitosan nanofibers | – | Maryskova et al., | |
| BPA, 17α-ethinylestradiol | Free | SA | Hofmann and Schlosser, | |
| BPA, 17α-ethinylestradiol, 17α-estradiol, 17α-estradiol 17–acetate, estriol, estrone | Enzymatic membrane reactor | SA | Nguyen et al., | |
| All 15 US EPA priority PAHs | Free | ABTS | Zeng et al., | |
| Naphthalene, phenanthrene | Nonionic surfactant-modified clay | – | Chang et al., | |
| Benzo[a]pyrene, phenanthrene | Free | – | Balcazar-Lopez et al., | |
| Atrazine | Free | ABTS, HBT, HPI, TEMPO, SA, VA, VAN | Ashe et al., | |
| Chlorpyrifos | Bacterial WlacD expressed in | Surface display | – | Liu et al., |
| Atrazine, chlorothalonil, chlorpyrifos, isoproturon, pyrimethanil | Free | ABTS, AS, guaiacol, HBT, SA, VA, VAN | Jin et al., | |
| Atrazine, isoproturon | In culture | – | Huang et al., | |
| Ametryn, atrazine, clofibric acid, fenoprop, pentachlorophenol, propoxur | Enzymatic membrane reactor | SA | Nguyen et al., | |
| Aflatoxin B1 and M1 | Free | ABTS, AS, SA | Loi et al., | |
All tested mediators are listed. ABTS, 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonate); AS, acetosyringone; HBT, 1-hydroxybenzotriazole; HPI, N-hydroxyphthalimide; TEMPO, 2,2,6,6-tetramethylpiperidinyloxyl; SA, syringaldehyde; SYA, syringic acid; VA, violuric acid; VAN, vanillin.
Laccase treatment of antibiotics.
| Amoxicillin, ampicillin, cloxacillin, penicillin G, penicillin V, oxacillin | Enzymatic membrane reactor | 10 μg/L antibiotics, 1 mM SA, starting pH 6, 25°C, 0.07 m/s flow, tangential configuration | 54–100% after 24 h | Increased ( | Becker et al., | |
| Sulfapyridine, sulfathiazole | Free | 16–20 mg/L antibiotic, 50–55 U/L laccase, 0.8 mM VA, pH 4.5, 25°C, 135 rpm | 100% after 8 h | NR | Rodriguez-Rodriguez et al., | |
| Sulfadimethoxine, sulfamonomethoxine | Free | 50 mg/L antibiotic, 6 U/mL, 1 mM ABTS or VA, pH 4.1, 30°C, 8% glycerol | NR | Weng et al., | ||
| Sulfadimethoxine, sulfamonomethoxine | Free | 50 mg/L antibiotic, 6 U/mL laccase, 8% glycerol; 1 mM ABTS, pH 4, 50–60°C; 1 mM VA, pH 4, 40–60°C; 2 mM SA, pH 6, 50°C | 100% after 30 min with ABTS; 100% after 15 min with VA; >95% after 60 min with SA | Reduced ( | Weng et al., | |
| Sulfamethoxazole | Free | 1,100 μg/L antibiotic, 1 mM HBT, 25°C, 70 rpm | 41% after 22 h | NR | Yang et al., | |
| Sulfamethoxazole | Enzymatic membrane reactor | 830 μg/L d antibiotic, 70–100 μM/min laccase, 5 μM SA, 3 g/L granular activated carbon | 65% | Increased (ToxScreen3 assay with | Nguyen et al., | |
| Sulfadiazine, sulfamethazine, sulfamethoxazole | Oriented immobilization on Fe3O4 nanoparticles | 50 mg/L antibiotic, 0.2 U/mL laccase, 1 mM AS, SA or SYA, pH 5 | >95% after 30 min | Reduced ( | Shi et al., | |
| Sulfamethoxazole | Free | 73–93 μM antibiotic, mediator/laccase ratio: 1.1 (ABTS), 1.7 (SA) or 2.4 (AS), pH 6, 25°C, static | 100% | Reduced (algae | Margot et al., | |
| Sulfamethoxazole, sulfathiazole | On porous silica beads | 50 mg/L antibiotic, 1 U/mL laccase, 1 mM HBT, pH 5, 40°C, 50 rpm | 76–85% after 1 h | Reduced ( | Rahmani et al., | |
| Sulfadimethoxine | Free | Per gram soil: 2 μg antibiotic, 10 U laccase, 8 μmol ABTS or HBT, 1 mg peat; room temperature | >90% after 72 h | NR | Singh R. et al., | |
| Sulfadiazine, sulfamethoxazole, | In culture | 25 mg/L antibiotics, 600 U/L laccase, 0.274 g/L ABTS, 28°C | 84% after 6 h | Reduced ( | Li et al., | |
| Sulfamethoxazole | Surface display | 30 μM antibiotic, 0.25 U/mL laccase, pH 5, 37°C, 250 rpm | 44% after 30 h | NR | Chen et al., | |
| Sulfamethoxazole | Free | 250 μM antibiotic, 3 U/mL laccase, 500 μM SA, pH 5, 22°C, 120 rpm | 87% after 22 h | NR | Hofmann and Schlosser, | |
| Sulfabenzamide, sulfadiazine, sulfadimethoxine, sulfamerazine, sulfamethizole, sulfamethoxazole, sulfamethoxypyridazine, sulfanitran, sulfapyridine, sulfisomidine, sulfisoxazole, sulfathiazole, | Enzymatic membrane reactor | 10 μg/L antibiotics, 10 or 1,000 μM SA, starting pH 6, 25°C, 0.07 m/s flow, tangential configuration | 43–97% after 24 h with 10 μM SA; 50–100% after 24 h with 1,000 μM SA | Increased ( | Becker et al., | |
| Sulfamethoxazole | On granular activated carbon, continuous flow packed-bed reactor | 0.5 mg/L antibiotic, 0.4 g/mL laccase, 28°C, 8.5 BV/h (BV: 17 mL) | 100% for 4,000 BV, 70% after 12,000 BV (60 d) | NR | Nguyen et al., | |
| Sulfadiazine, sulfamethazine, sulfamethoxazole, sulfapyridine, sulfathiazole | Free | 10 mg/L antibiotics, 0.5 mg/mL laccase, 0.5 mM SA, pH 6, 25°C, 200 rpm | 73–80% after 15 min; 97–99% after 180 min | NR | Ding et al., | |
| Chlortetracycline, doxycycline, oxytetracycline, tetracycline | Free | 100 μM antibiotic, 10 nkat/mL laccase, 0.2 mM HBT, pH 4.5, 30°C, 150 rpm | Chlortetracycline and doxycycline: 100% after 15 min; tetracycline and oxytetracycline: 100% after 1 h | Reduced ( | Suda et al., | |
| Tetracycline | Enzymatic membrane reactor | 20 mg/L antibiotic, 0.002 g/L laccase, pH 6, 25°C, batch | 0.34 mg/h for 10 d | NR | de Cazes et al., | |
| Tetracycline | Enzymatic membrane reactor | 20 mg/L antibiotic, 10 g/L laccase, 1.4 μm pore size, 25 cm length, tangential (10 L/h), 25°C, 8 L/h/m2 permeation | >200 mg/h/m2 for 24 h | NR | de Cazes et al., | |
| Tetracycline | Free | 100 μg/mL antibiotic, 17.5 μg/mL laccase, pH 7, 20°C | 78% after 18 h | Reduced ( | Llorca et al., | |
| Chlortetracycline, doxycycline, oxytetracycline, tetracycline | Enzymatic membrane reactor | 10 μg/L antibiotics, 10 μM SA, starting pH 6, 25°C, 0.07 m/s flow, tangential configuration | 85–98% after 24 h | Increased ( | Becker et al., | |
| Chlortetracycline, doxycycline, oxytetracycline, tetracycline | Free | 10 mg/L antibiotics, 0.5 mg/mL laccase, 0.5 mM SA, pH 6, 25°C, 200 rpm | 61–100% after 15 min; 95–100% after 180 min | NR | Ding et al., | |
| Oxytetracycline, tetracycline | Magnetic cross-linked enzyme aggregates | 100 μg/mL antibiotic, 40 U/mL laccase, pH 6, 25°C | 80% after 12 h | Reduced ( | Yang et al., | |
| Flumequine | Free | 90 mg/L antibiotic, 6 U/mL laccase, 1.35 mM ABTS, pH 4, 39°C, 150 rpm | 98% after 2 h | NR | Ashrafi et al., | |
| Ciprofloxacin | Free | 10 mg/L antibiotic, 0.02% (w/v) laccase, pH 6, 60°C, 200 rpm ultrasound (75 W, 22 kHz, 50% duty cycle), | 51% after 5 h | NR | Sutar and Rathod, | |
| Cinoxacin, ciprofloxacin, danofloxacin, difloxacin, enoxacin, enrofloxacin, flumequine, marbofloxacin, nalidixic acid, norfloxacin, ofloxacin, orbifloxacin, oxolinic acid, pipemidic acid | Enzymatic membrane reactor | 10 μg/L antibiotics, 10 or 1,000 μM SA, starting pH 6, 25°C, 0.07 m/s flow, tangential configuration | 0–84% after 24 h with 10 μM SA; 15–93% after 24 h with 1,000 μM SA | Increased ( | Becker et al., | |
| Ciprofloxacin, enoxacin, enrofloxacin, norfloxacin, ofloxacin | Free | Laccase/SA (10 mg/L antibiotics, 0.5 mg/mL laccase, 0.5 mM SA, pH 6, 25°C, 200 rpm) coupled with soil (0.05 g/mL) adsorption | 91–99% after 15 min; 96–100% after 180 min; enoxacin: 74% after 15 min with only laccase and SA | NR | Ding et al., | |
| Ciprofloxacin, norfloxacin | Free | 50 mg/L antibiotic, 0.4 U/mL laccase, 0.5 mM AS, pH 8, 35°C | >70% after 4 h; >90% after 24 h | Reduced ( | Blánquez et al., | |
| Trimethoprim | Enzymatic membrane reactor | 10 μg/L antibiotic, 1 mM SA, starting pH 6, 25°C, 0.07 m/s flow, tangential configuration | 66.8% after 24 h | Increased ( | Becker et al., | |
| Trimethoprim | Magnetic cross-linked enzyme aggregates | 100 μg/L antibiotic, 1 U/mL laccase, 0.1 mM ABTS, pH 7, 20°C, 125 rpm | 47% after 6 h; 60% after 12 h | NR | Kumar and Cabana, | |
| Metronidazole | Enzymatic membrane reactor | 10 μg/L antibiotic, 10 μM SA, starting pH 6, 25°C, 0.07 m/s flow, tangential configuration | 25.9% after 24 h | Increased ( | Becker et al., | |
Only the best reaction parameters are shown. ABTS, 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonate); AS, acetosyringone; BV, bed volume; HBA, 4-hydroxybenzyl alcohol; HBT, 1-hydroxybenzotriazole; NR, not reported; SA, syringaldehyde; SYA, syringic acid; VA, violuric acid.
Laccase transformation of diclofenac, carbamazepine, and triclosan since 2010.
| Diclofenac (anti-inflammatory) | Free | – | 100% after 12 h | Tran et al., | |
| Free | HBT, SA, VA | 100% after 1–8 h | Lloret et al., | ||
| Free | − | 95% after 4.5 h | Marco-Urrea et al., | ||
| Free | − | 80% after 12 d | Margot et al., | ||
| Free | − | 100% after 2 d | Margot et al., | ||
| Free | − | 90% after 5 h | Margot et al., | ||
| Mesoporous silica spheres | – | 70 or 90% at pH 5 (individually or in mixtures); 30% in real wastewater for over 64 reactor volumes | Nair et al., | ||
| Free | HBT | 16% after 22 h | Yang et al., | ||
| Free or combined cross-linked enzyme aggregates of laccase, versatile peroxidase and glucose oxidase | – | 100% after 14 h | Touahar et al., | ||
| Free | SA | 100% after 51 min | Sathishkumar et al., | ||
| Free | HBT, SA | >80% after 24 h | Nguyen et al., | ||
| Enzymatic membrane reactor | SA | 80% | Nguyen et al., | ||
| Enzymatic membrane reactor with granular activated carbon addition | SA | 80% | Nguyen et al., | ||
| Enzymatic membrane reactor | HBT, SA | 50% for 72 h (9 hydraulic retention time) | Nguyen et al., | ||
| Polyvinyl alcohol/chitosan/multi-walled carbon nanotubes composite nanofibrous membrane | – | 100% after 6 h | Xu et al., | ||
| On granular activated carbon, continuous flow packed-bed reactor | – | 100% for 8000 BV | Nguyen et al., | ||
| Enzymatic membrane reactor | HBT | 60% for 72 h (9 hydraulic retention time) | Nguyen et al., | ||
| Free | SA | 100% after 22 h | Hofmann and Schlosser, | ||
| Magnetic cross-linked enzyme aggregates | – | 85% after 6 h; 95% after 12 h | Kumar and Cabana, | ||
| Free | – | 100% after 24 h | Singh et al., | ||
| Cross-linked carbon nanotubes-based biocatalytic membranes | – | 94% after 48 h | Ji et al., | ||
| Free | – | 50% after 8 h | Rodríguez-Delgado et al., | ||
| Carbamazepine (anticonvulsant) | Free | HBT | 60% after 48 h (repeated treatment every 8 h) | Hata et al., | |
| Free | – | 37.5% after 12 h | Tran et al., | ||
| Enzymatic membrane reactor with granular activated carbon addition | SA | 70% | Nguyen et al., | ||
| Hybrid bioreactor of cross-linked laccase aggregates and polysulfone hollow fiber microfilter membrane | – | 93% after 72 h | Ba et al., | ||
| Enzyme membrane reactor | HBT, SA | 60% for 72 h (9 hydraulic retention time) | Nguyen et al., | ||
| Biocatalytic TiO2 particle suspension membrane hybrid reactor | p-coumaric acid | 71% after 96 h | Ji et al., | ||
| Cross-linked carbon nanotubes-based biocatalytic membrane | – | 60% after 48 h | Ji et al., | ||
| On granular activated carbon, continuous flow packed-bed reactor | – | 100% for 5,000 BV | Nguyen et al., | ||
| Triclosan (biocide) | Free | HBT, SA | 90% after 24 h | Murugesan et al., | |
| Chitosan conjugation | – | 100% after 6 h | Cabana et al., | ||
| Control porosity carrier silica beads | – | 60% after 60 min | Songulashvili et al., | ||
| Free | – | 90% after 140 min | Margot et al., | ||
| Free | HBT, SA | >80% after 24 h | Nguyen et al., | ||
| Mesoporous silica beads | – | 100% for 23 h | Debaste et al., | ||
| Free | – | 95% after 8 h | Ramírez-Cavazos et al., | ||
| White-rot fungi (commercial) | Vinyl-modified poly(acrylic acid)/SiO2 mesoporous nanofibers | – | 65% after 2 h; 92% after 24 h | Xu et al., | |
| Free | ABTS | 100% after 6 h | Otto et al., | ||
| Free | – | 90% after 5.5 h | Garcia-Morales et al., | ||
| Enzymatic membrane reactor | – | 100% for 72 h (9 hydraulic retention time) | Nguyen et al., | ||
| Free | – | 83.8% after 5 h | Melo et al., | ||
| Free | – | 0.5757 h−1 | Sun et al., | ||
| Core-shell magnetic copper alginate beads | HBT | 89.6% after 8 h | Le et al., | ||
| Free | SA | 90% after 22 h | Hofmann and Schlosser, |
When multiple mediators were used, only the most efficient one(s) are shown. SA, syringaldehyde; VA, violuric acid.